Vestal Point Capital »

Chimerix shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Chimerix (CMRX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Chimerix

Tip: Access up to 7 years of quarterly data

All positions including Chimerix held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chimerix by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 1.4M 0.88

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Chimerix

RA Capital Management
Vanguard Group
Monaco Asset Management SAM
Armistice Capital
Acadian Asset Management
Citadel Advisors
Renaissance Technologies
Vestal Point Capital
Bridgeway Capital Management
Millennium Management
BlackRock
Geode Capital Management
Acuitas Investments
Goldman Sachs Group
Bank of New York Mellon

View all funds holding Chimerix